Test Session 1

Mar 17, 2023 10:00am ‐ Mar 31, 2023 10:00am

Identification: testses1

Learning Objectives:
  • Objective 1
  • Objective 2
  • Objective 3
  • Objective 4

Speaker(s):


Real-World Case Discussion: Intervene With Jakafi® (ruxolitinib) at Diagnosis in Adults With Intermediate- or High-Risk Myelofibrosis

Jun 13, 2023 3:00pm ‐ Jun 13, 2023 4:00pm

Identification: web230613

Speaker(s):


Real-World Case Discussion: Intervene With Jakafi® (ruxolitinib) at Diagnosis in Adults With Intermediate- or High-Risk Myelofibrosis

Jun 14, 2023 4:00pm ‐ Jun 14, 2023 5:00pm

Identification: web230614

Speaker(s):


Real-World Case Discussion: Intervene With Jakafi® (ruxolitinib) at Diagnosis in Adults With Intermediate- or High-Risk Myelofibrosis

Jun 15, 2023 12:00pm ‐ Jun 15, 2023 1:00pm

Identification: web230615

Speaker(s):


Real-World Case Discussion: Intervene With Jakafi® (ruxolitinib) at Diagnosis in Adults With Intermediate- or High-Risk Myelofibrosis

Jun 20, 2023 3:00pm ‐ Jun 20, 2023 4:00pm

Identification: web230620

Speaker(s):


Real-World Case Discussion: Intervene With Jakafi® (ruxolitinib) at Diagnosis in Adults With Intermediate- or High-Risk Myelofibrosis

Jun 21, 2023 12:00pm ‐ Jun 21, 2023 1:00pm

Identification: web230621

Speaker(s):